Evidence map›Paper›PMID 33467726›Full record

ArticleInternational journal of molecular sciences2021

Comparative Proteomic Analysis of the Mesenchymal Stem Cells Secretome from Adipose, Bone Marrow, Placenta and Wharton's Jelly.

Sungho Shin, Jeongmin Lee, Yumi Kwon, Kang-Sik Park, Jae-Hoon Jeong, Suk-Joo Choi, Sa Ik Bang, Jong Wook Chang, Cheolju Lee

Open access · goldAbstract readComparative Study
In one paragraph

Article in International journal of molecular sciences, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 127 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
127citing papers in PubMed, 1 pooled it
22.5field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

127 citing papers in PubMed, 1 synthesis or guideline pooled it, 206 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Review
  4. Review
  5. Review
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Review
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Review
  18. Article
  19. Review
  20. Article

67 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 4 institutions in 1 country.

Sungho ShinCenter for Theragnosis, Korea Institute of Science and Technology, Seoul 02792, Korea.ORCID 0000-0002-4206-1229
Jeongmin LeeStem Cell & Regenerative Medicine Institute, Samsung Medical Center, Seoul 06351, Korea.ORCID 0000-0003-3983-3950
Yumi KwonCenter for Theragnosis, Korea Institute of Science and Technology, Seoul 02792, Korea.
Kang-Sik ParkKHU-KIST Department of Converging Science and Technology, Kyung Hee University, Seoul 02447, Korea.
Jae-Hoon JeongDivision of Radiation Cancer Research, Korea Institute of Radiological and Medical Sciences, Seoul 01812, Korea.
Suk-Joo ChoiDepartment of Obstetrics and Gynecology, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul 06351, Korea.
Sa Ik BangDepartment of Plastic Surgery, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul 06351, Korea.
Jong Wook ChangStem Cell & Regenerative Medicine Institute, Samsung Medical Center, Seoul 06351, Korea.
Cheolju LeeCenter for Theragnosis, Korea Institute of Science and Technology, Seoul 02792, Korea.
Samsung Medical Center · KRKyung Hee University · KRKorea Institute of Radiological and Medical Sciences · KRKorea Institute of Science and Technology · KR

Funding

KIST intramuralKorea Health Industry Development Institute HI14C2746Korea Health Industry Development Institute HI14C3484National Research Foundation of Korea 2017M3A9F9030559National Research Foundation of Korea 2017M3C9A5031595National Research Foundation of Korea 2020R1A2C2003685
6 · The paper itself

Abstract

Mesenchymal stem cells (MSCs) have the potential to be a viable therapy against various diseases due to their paracrine effects, such as secretion of immunomodulatory, trophic and protective factors. These cells are known to be distributed within various organs and tissues. Although they possess the same characteristics, MSCs from different sources are believed to have different secretion potentials and patterns, which may influence their therapeutic effects in disease environments. We characterized the protein secretome of adipose (AD), bone marrow (BM), placenta (PL), and Wharton's jelly (WJ)-derived human MSCs by using conditioned media and analyzing the secretome by mass spectrometry and follow-up bioinformatics. Each MSC secretome profile had distinct characteristics depending on the source. However, the functional analyses of the secretome from different sources showed that they share similar characteristics, such as cell migration and negative regulation of programmed cell death, even though differences in the composition of the secretome exist. This study shows that the secretome of fetal-derived MSCs, such as PL and WJ, had a more diverse composition than that of AD and BM-derived MSCs, and it was assumed that their therapeutic potential was greater because of these properties.

Indexed as

Adipose TissueBone MarrowBone Marrow CellsCell DifferentiationCell ProliferationChromatography, LiquidCluster AnalysisCoculture TechniquesComputational BiologyCulture Media, ConditionedCulture Media, Serum-FreeFemaleHumansMass SpectrometryMesenchymal Stem CellsOsteogenesisCulture Media, ConditionedCulture Media, Serum-Freeadiposebone marrowmass spectrometrymesenchymal stem cellsplacentasecretomeWharton’s jelly

Identifiers

PMID33467726
PMCPMC7829982
OpenAlexW3118496755

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.